Excellent outcome in patients with stage I germ cell tumors of the testes: a study of the Children's Cancer Group/Pediatric Oncology Group

J Pediatr Surg. 2003 Mar;38(3):319-24; discussion 319-24. doi: 10.1053/jpsu.2003.50101.

Abstract

Background/purpose: The aim of this study was to correlate outcomes in patients with stage I testicular germ cell tumors with compliance to surgical guidelines and to confirm previous single-institution experiences that show excellent disease-free survival rates when treated with orchiectomy alone.

Methods: Sixty-three patients were entered into this intergroup study (Children's Cancer Group 8881/Pediatric Oncology Group 9048) between 1990 and 1996. Surgical guidelines for orchiectomy included an inguinal approach, early vascular control of the cord structures, and a hemiscrotectomy if a transscrotal violation occurred. Failure of tumor marker normalization or subsequent elevation suggested advanced disease requiring further surgery and chemotherapy. Survival curves were compared using the log-rank test.

Results: The median age was 16 months (range, 1 month to 5.6 years). Progression of disease occurred in 11 patients. The 6-year event-free survival (EFS) was 78.5% + 7%. The overall 6-year survival rate was 100%. Adherence to all guidelines was confirmed in only 43 patients (69%). Overall, there was no statistical significance in event-free survival rates between patients who had a correct surgical approach and all patients who had surgical violations; however, 4 patients with transscrotal violations showed a significantly higher rate of disease recurrence.

Conclusions: Patients with stage I germ cell tumors of the testes have excellent survival rates when treated with surgery alone. Despite numerous surgical guideline violations, event-free survival in this multiinstitutional study was similar to previous single-institution reports. All patients with relapse or progression of their disease appear to be cured with further surgical excision and chemotherapy.

Publication types

  • Multicenter Study

MeSH terms

  • Chemotherapy, Adjuvant
  • Child, Preschool
  • Disease-Free Survival
  • Germinoma / drug therapy
  • Germinoma / mortality
  • Germinoma / pathology
  • Germinoma / surgery*
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Neoplasm Staging
  • Orchiectomy*
  • Remission Induction
  • Retrospective Studies
  • Survival Analysis
  • Testicular Neoplasms / drug therapy
  • Testicular Neoplasms / mortality
  • Testicular Neoplasms / pathology
  • Testicular Neoplasms / surgery*
  • Treatment Outcome